Ocular Therapeutix (OCUL) Return on Capital Employed Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4,853.00 |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | 3,490.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,490.00 |
| Dec 31, 2025 | 1,585.00 |
| Sep 30, 2025 | -906.00 |
| Jun 30, 2025 | -1,031.00 |
| Mar 31, 2025 | -789.00 |
| Dec 31, 2024 | 250.00 |
| Sep 30, 2024 | 712.00 |
| Jun 30, 2024 | 897.00 |
| Mar 31, 2024 | 490.00 |
| Dec 31, 2023 | -683.00 |
| Sep 30, 2023 | 1,150.00 |
| Jun 30, 2023 | 1,351.00 |
| Mar 31, 2023 | 5,160.00 |
| Dec 31, 2022 | 5,549.00 |
| Sep 30, 2022 | 4,779.00 |
| Jun 30, 2022 | 3,697.00 |
| Mar 31, 2022 | 3,915.00 |
| Dec 31, 2021 | 5,240.00 |
| Sep 30, 2021 | 5,843.00 |
| Jun 30, 2021 | 5,711.00 |
| Mar 31, 2021 | 8,331.00 |
| Dec 31, 2020 | 9,222.00 |
| Sep 30, 2020 | 1,340.00 |
| Jun 30, 2020 | -2,633.00 |
| Mar 31, 2020 | -6,255.00 |
| Dec 31, 2019 | -5,808.00 |
| Sep 30, 2019 | -5,162.00 |
| Jun 30, 2019 | -3,728.00 |
| Mar 31, 2019 | -4,119.00 |
| Dec 31, 2018 | -5,969.00 |
| Sep 30, 2018 | -6,444.00 |
| Jun 30, 2018 | -5,488.00 |
| Mar 31, 2018 | -7,236.00 |
| Dec 31, 2017 | -9,715.00 |
| Sep 30, 2017 | -5,553.00 |